|
The Mapi Values team provides consultancy on the steps required to effectively demonstrate treatment benefits using patients’ reports of symptoms and functions.
Boasting a wealth of experience in clinical research, our PRO team carefully integrates the PRO endpoint through a combination of powerful RCT design, cutting-edge analysis, insightful interpretation and effective publication. Our ability to exercise scientific rigor while maintaining a pragmatic approach to PRO research sets us apart as the provider of choice in an increasingly competitive marketplace.
Involving our clients every step of the way, our meticulous processes ensure that any PRO strategy is aligned with the final goal for the PRO assessment, which might be:
- Product Labeling and Market Authorization
- Direct to Consumer Advertising in the US
- Peer-reviewed Publications
|
- Conferences and Symposia
- Value arguments for Market Access
- Communications to Prescribers and Payers
|
Whether establishing primary or secondary endpoints, the PRO measures we develop and validate internationally cover a range of both simple and complex concepts including, though not limited to:
- Symptoms
- Health-Related Quality of Life
- Satisfaction
- Goal Assessment
|
- Compliance/Adherence
- Work Productivity
- Functional Impact
- Patient Preference
|
|